Teresa Company Messa: ”Evolution, Commitment, and Innovation” Perfectly Sum up Last Week’s Event
Teresa Company Messa, Market Development Manager at Werfen, shared on LinkedIn:
”Evolution, commitment, and innovation
Three big words, but ones that perfectly sum up last week’s event: the launch of the 70 Series, a new generation of analyzers that mark another step forward in our mission to advance hemostasis diagnostics.
And there could be no better setting than La Pedrera.
Just as Gaudí challenged the limits of his time to transform architecture, we continue to push the limits of technology to transform diagnostics.
And for those of you who are not part of this world, you may ask yourselves: what does this have to do with me?
Everything.
Because behind every sample there is a person, and that person could be you, it could be me.
At Werfen, we work every day with a firm commitment to ensuring the highest quality, accuracy, and service for laboratory professionals and, ultimately, for patients.”
Stay updated with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology